Top

BMC Surgery

Published in:

Open Access 01-12-2022 | Hepatitis B | Research

Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis

Authors: Liangliang Xu, Fuzhen Dai, Peng Wang, Lian Li, Ming Zhang, Mingqing Xu

Published in: BMC Surgery | Issue 1/2022

Abstract

Background

Liver cirrhosis is a well-known risk factor for carcinogenesis of hepatocellular carcinoma (HCC). The aim of the present study was to construct individual prognostic models for HCC with cirrhosis.

Methods

The clinical differences between HCC patients with and without cirrhosis were compared using a large cohort of 1003 cases. The patients with cirrhosis were randomly divided into a training cohort and a validation cohort in a ratio of 2:1. Univariate and multivariate analyses were performed to reveal the independent risk factors for recurrence-free survival (RFS) and overall survival (OS) in HCC patients with cirrhosis. These factors were subsequently used to construct nomograms.

Results

Multivariate analyses revealed that five clinical variables (hepatitis B e antigen (HBeAg) positivity, alpha-fetoprotein (AFP) level, tumour diameter, microvascular invasion (MVI), and satellite lesions) and seven variables (HBeAg positivity, AFP level, tumour diameter, MVI, satellite lesions, gamma-glutamyl transpeptidase level, and histological differentiation) were significantly associated with RFS and OS, respectively. The C-indices of the nomograms for RFS and OS were 0.739 (P < 0.001) and 0.789 (P < 0.001), respectively, in the training cohort, and 0.752 (P < 0.001) and 0.813 (P < 0.001), respectively, in the validation cohort. The C-indices of the nomograms were significantly higher than those of conventional staging systems (P < 0.001). The calibration plots showed optimal consistence between the nomogram-predicted and observed prognoses.

Conclusions

The nomograms developed in the present study showed good performance in predicting the prognoses of HCC patients with hepatitis B virus-associated cirrhosis.

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. https://doi.org/10.3322/caac.21262.CrossRefPubMed

Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018. https://doi.org/10.1038/nrdp.2016.18.CrossRefPubMed

El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264-73.e1. https://doi.org/10.1053/j.gastro.2011.12.061.CrossRefPubMed

Liu J, Fan D. Hepatitis B in China. Lancet. 2007;369(9573):1582–3. https://doi.org/10.1016/s0140-6736(07)60723-5.CrossRefPubMed

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32. https://doi.org/10.3322/caac.21338.CrossRefPubMed

Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–38. https://doi.org/10.1055/s-2007-1007122.CrossRefPubMed

Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M, et al. Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol. 2013;58(4):724–9. https://doi.org/10.1016/j.jhep.2012.11.009.CrossRefPubMed

Ioannou GN, Bryson CL, Weiss NS, Miller R, Scott JD, Boyko EJ. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology. 2013;57(1):249–57. https://doi.org/10.1002/hep.25800.CrossRefPubMed

Fattovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, et al. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology. 1995;21(1):77–82.PubMed

10.

Flemming JA, Yang JD, Vittinghoff E, Kim WR, Terrault NA. Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model. Cancer. 2014;120(22):3485–93. https://doi.org/10.1002/cncr.28832.CrossRefPubMed

11.

Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5 Suppl 1):S35-50.CrossRef

12.

Tarao K, Nozaki A, Ikeda T, Sato A, Komatsu H, Komatsu T, et al. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment. Cancer Med. 2019;8(3):1054–65. https://doi.org/10.1002/cam4.1998.CrossRefPubMedPubMedCentral

13.

Arnaoutakis DJ, Mavros MN, Shen F, Alexandrescu S, Firoozmand A, Popescu I, et al. Recurrence patterns and prognostic factors in patients with hepatocellular carcinoma in noncirrhotic liver: a multi-institutional analysis. Ann Surg Oncol. 2014;21(1):147–54. https://doi.org/10.1245/s10434-013-3211-3.CrossRefPubMedPubMedCentral

14.

Sasaki K, Shindoh J, Margonis GA, Nishioka Y, Andreatos N, Sekine A, et al. Effect of background liver cirrhosis on outcomes of hepatectomy for hepatocellular carcinoma. JAMA Surg. 2017;152(3):e165059. https://doi.org/10.1001/jamasurg.2016.5059.CrossRefPubMed

15.

Saunders JB, Walters JR, Davies AP, Paton A. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed). 1981;282(6260):263–6. https://doi.org/10.1136/bmj.282.6260.263.CrossRef

16.

Gines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7(1):122–8.CrossRef

17.

Wang Y, Li J, Xia Y, Gong R, Wang K, Yan Z, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188–95. https://doi.org/10.1200/jco.2012.41.5984.CrossRefPubMed

18.

Liang W, Zhang L, Jiang G, Wang Q, Liu L, Liu D, et al. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. J Clin Oncol. 2015;33(8):861–9. https://doi.org/10.1200/jco.2014.56.6661.CrossRefPubMed

19.

He Y, Zhu Z, Chen Y, Chen F, Wang Y, Ouyang C, et al. Development and validation of a novel diagnostic nomogram to differentiate between intestinal tuberculosis and Crohn’s disease: a 6-year prospective multicenter study. Am J Gastroenterol. 2019;114(3):490–9. https://doi.org/10.14309/ajg.0000000000000064.CrossRefPubMed

20.

Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–80. https://doi.org/10.1016/s1470-2045(14)71116-7.CrossRefPubMedPubMedCentral

21.

Zhou L, Rui JA, Ye DX, Wang SB, Chen SG, Qu Q. Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection. World J Surg. 2008;32(8):1748–56. https://doi.org/10.1007/s00268-008-9615-8.CrossRefPubMed

22.

Rodriguez-Peralvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, Burroughs AK. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol. 2013;20(1):325–39. https://doi.org/10.1245/s10434-012-2513-1.CrossRefPubMed

23.

Okusaka T, Okada S, Ueno H, Ikeda M, Shimada K, Yamamoto J, et al. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer. 2002;95(9):1931–7. https://doi.org/10.1002/cncr.10892.CrossRefPubMed

24.

Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696–9.CrossRef

25.

Zhang Y, Lei X, Xu L, Lv X, Xu M, Tang H. Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection. BMC Surg. 2022;22(1):233. https://doi.org/10.1186/s12893-022-01682-0.CrossRefPubMedPubMedCentral

26.

Cheng Z, Yang P, Lei Z, Zhang B, Si A, Yan Z, et al. Nomograms for prediction of long-term survival in elderly patients after partial hepatectomy for hepatocellular carcinoma. Surgery. 2017;162(6):1231–40. https://doi.org/10.1016/j.surg.2017.07.019.CrossRefPubMed

27.

Zou Q, Li J, Wu D, Yan Z, Wan X, Wang K, et al. Nomograms for pre-operative and post-operative prediction of long-term survival of patients who underwent repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg Oncol. 2016;23(8):2618–26. https://doi.org/10.1245/s10434-016-5136-0.CrossRefPubMed

28.

Everhart JE, Wright EC, Goodman ZD, Dienstag JL, Hoefs JC, Kleiner DE, et al. Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology. 2010;51(2):585–94. https://doi.org/10.1002/hep.23315.CrossRefPubMed

29.

WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015.

30.

Di Bisceglie AM, Hoofnagle JH. Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer. 1989;64(10):2117–20.CrossRef

31.

Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology. 1994;19(1):61–6.CrossRef

32.

Vora SR, Zheng H, Stadler ZK, Fuchs CS, Zhu AX. Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma. Oncologist. 2009;14(7):717–25. https://doi.org/10.1634/theoncologist.2009-0038.CrossRefPubMed

33.

Ma WJ, Wang HY, Teng LS. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy. World J Surg Oncol. 2013;11:212. https://doi.org/10.1186/1477-7819-11-212.CrossRefPubMedPubMedCentral

34.

Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295(1):65–73. https://doi.org/10.1001/jama.295.1.65.CrossRefPubMed

35.

Geier A, Gartung C, Dietrich CG. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002;347(21):1721–2. https://doi.org/10.1056/nejm200211213472119.CrossRefPubMed

36.

Shen J, Liu J, Li C, Wen T. The prognostic significance of serum HBeAg on the recurrence and long-term survival after hepatectomy for hepatocellular carcinoma: a propensity score matching analysis. J Viral Hepat. 2018;25(9):1057–65. https://doi.org/10.1111/jvh.12911.CrossRefPubMed

37.

Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38(4):263–355. https://doi.org/10.1080/20014091084227.CrossRefPubMed

38.

Carr BI, Pancoska P, Branch RA. Low alpha-fetoprotein hepatocellular carcinoma. J Gastroenterol Hepatol. 2010;25(9):1543–9. https://doi.org/10.1111/j.1440-1746.2010.06303.x.CrossRefPubMed

39.

Carr BI, Guerra V, Giannini EG, Farinati F, Ciccarese F, Rapaccini GL, et al. Low alpha-fetoprotein HCC and the role of GGTP. Int J Biol Markers. 2014;29(4):e395-402. https://doi.org/10.5301/jbm.5000092.CrossRefPubMed

40.

Ju MJ, Qiu SJ, Fan J, Zhou J, Gao Q, Cai MY, et al. Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation. J Gastroenterol. 2009;44(6):635–42. https://doi.org/10.1007/s00535-009-0050-x.CrossRefPubMed

41.

Lei Z, Li J, Wu D, Xia Y, Wang Q, Si A, et al. Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the milan criteria. JAMA Surg. 2016;151(4):356–63. https://doi.org/10.1001/jamasurg.2015.4257.CrossRefPubMed

42.

Fu YP, Yi Y, Huang JL, Jing CY, Sun J, Ni XC, et al. Prognostic nomograms stratify survival of patients with hepatocellular carcinoma without portal vein tumor thrombosis after curative resection. Oncologist. 2017;22(5):561–9. https://doi.org/10.1634/theoncologist.2016-0231.CrossRefPubMedPubMedCentral

43.

Carr BI, Pancoska P, Branch RA. Significance of increased serum GGTP levels in HCC patients. Hepatogastroenterology. 2010;57(101):869–74.PubMed

44.

Feng LH, Dong H, Lau WY, Yu H, Zhu YY, Zhao Y, et al. Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2017;143(2):293–303. https://doi.org/10.1007/s00432-016-2286-1.CrossRefPubMed

45.

Wang CC, Iyer SG, Low JK, Lin CY, Wang SH, Lu SN, et al. Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol. 2009;16(7):1832–42. https://doi.org/10.1245/s10434-009-0448-y.CrossRefPubMed

46.

Yeh CN, Chen MF, Lee WC, Jeng LB. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol. 2002;81(4):195–202. https://doi.org/10.1002/jso.10178.CrossRefPubMed

47.

An C, Kim DW, Park YN, Chung YE, Rhee H, Kim MJ. Single hepatocellular carcinoma: preoperative MR imaging to predict early recurrence after curative resection. Radiology. 2015;276(2):433–43. https://doi.org/10.1148/radiol.15142394.CrossRefPubMed

48.

Zhou L, Rui JA, Wang SB, Chen SG, Qu Q, Chi TY, et al. Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. Eur J Surg Oncol. 2006;32(7):767–72. https://doi.org/10.1016/j.ejso.2006.03.050.CrossRefPubMed

49.

Poon RT, Ng IO, Fan ST, Lai EC, Lo CM, Liu CL, et al. Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol. 2001;19(12):3037–44. https://doi.org/10.1200/jco.2001.19.12.3037.CrossRefPubMed

50.

Sasaki K, Matsuda M, Ohkura Y, Kawamura Y, Inoue M, Hashimoto M, et al. In hepatocellular carcinomas, any proportion of poorly differentiated components is associated with poor prognosis after hepatectomy. World J Surg. 2014;38(5):1147–53. https://doi.org/10.1007/s00268-013-2374-1.CrossRefPubMed

51.

Zhou L, Rui JA, Wang SB, Chen SG, Qu Q. Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade. Eur J Surg Oncol. 2011;37(6):521–5. https://doi.org/10.1016/j.ejso.2011.03.137.CrossRefPubMed

52.

Shen J, Liu J, Li C, Wen T, Yan L, Yang J. The impact of tumor differentiation on the prognosis of HBV-associated solitary hepatocellular carcinoma following hepatectomy: a propensity score matching analysis. Dig Dis Sci. 2018;63(7):1962–9. https://doi.org/10.1007/s10620-018-5077-5.CrossRefPubMed

Title: Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis
Authors: Liangliang Xu
Fuzhen Dai
Peng Wang
Lian Li
Ming Zhang
Mingqing Xu
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Hepatitis B
Hepatocellular Carcinoma
Hepatocellular Carcinoma
Published in: BMC Surgery / Issue 1/2022
Electronic ISSN: 1471-2482
DOI: https://doi.org/10.1186/s12893-022-01789-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

A 6-year retrospective clinical review of iatrogenic ureteric injuries repaired in a resource-deprived setting

Sequential endoscopic and robot-assisted surgical solutions for a rare fungal spondylodiscitis, secondary lumbar spinal stenosis, and subsequent discal pseudocyst causing acute cauda equina syndrome: a case report

Glomus tumors around or in the knee: a case report and literature review

Quality of life following two different techniques of an open ventral hernia repair for large hernias: a prospective randomized study

Nine-year-long complex humeral nonunion salvaged by distraction osteogenesis technique: a case report and review of the literature

Development and validation of a prediction model of perioperative hypoglycemia risk in patients with type 2 diabetes undergoing elective surgery